Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction
jRCT2080221812Phase 3
- Sponsor
- Novartis
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sacubitril + valsartan in hypertension (HTN) and chronic kidney disease (CKD), sponsored by Novartis.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080221812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221812.